Related Posts
-
Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis -
European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development -
Critical Path Institute Receives Third Grant To Accelerate Tuberculosis Diagnostics
-
Critical Path Institute Receives Grant to Accelerate Development of Tuberculosis Treatments
-
CPTR Initiative Expands Focus to Include Drug Susceptibility Tests